Tech Company Financing Transactions

Blueprint Bio Funding Round

Private investors participated in a $475 thousand funding round for Blueprint Bio. The round was announced on 4/19/2017.

Transaction Overview

Company Name
Announced On
4/19/2017
Transaction Type
Venture Equity
Amount
$475,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 9 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
270 Newport Center Dr. 100
Newport Beach, CA 92660
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
Personalized medicine is about getting the right treatments to the right people at the right time. We believe that this requires a quantum leap in technology and know-how.
Profile
Blueprint Bio LinkedIn Company Profile
Social Media
Blueprint Bio Company Twitter Account
Company News
Blueprint Bio News
Facebook
Blueprint Bio on Facebook
YouTube
Blueprint Bio on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Matthew Nunez
  Matthew Nunez LinkedIn Profile  Matthew Nunez Twitter Account  Matthew Nunez News  Matthew Nunez on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/19/2017: Aspect Imaging venture capital transaction
Next: 4/19/2017: Mux venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary